Methotrexate Sodium is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp.. The primary component is Methotrexate Sodium.
Product ID | 0054-8550_033813cc-9c1e-4e82-ad44-7a3603925b40 |
NDC | 0054-8550 |
Product Type | Human Prescription Drug |
Proprietary Name | Methotrexate Sodium |
Generic Name | Methotrexate Sodium |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1994-08-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA040054 |
Labeler Name | West-Ward Pharmaceuticals Corp. |
Substance Name | METHOTREXATE SODIUM |
Active Ingredient Strength | 3 mg/1 |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1994-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA040054 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1994-08-01 |
Ingredient | Strength |
---|---|
METHOTREXATE SODIUM | 2.5 mg/1 |
SPL SET ID: | d71b1856-99d8-4a9e-9189-f87b6675f80a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0054-4550 | Methotrexate Sodium | Methotrexate Sodium |
0054-8550 | Methotrexate Sodium | Methotrexate Sodium |
63629-1472 | Methotrexate Sodium | Methotrexate Sodium |
66758-040 | Methotrexate Sodium | Methotrexate Sodium |
66758-041 | Methotrexate Sodium | Methotrexate Sodium |
70518-2711 | Methotrexate Sodium | Methotrexate Sodium |
75840-111 | METHOTREXATE SODIUM | METHOTREXATE SODIUM |
21695-111 | Methotrexate | Methotrexate sodium |
47335-235 | Methotrexate | Methotrexate Sodium |
50090-3418 | Methotrexate | Methotrexate Sodium |
63323-122 | Methotrexate | METHOTREXATE SODIUM |
63323-123 | Methotrexate | METHOTREXATE SODIUM |
70518-1251 | Methotrexate | Methotrexate Sodium |